Mortality from cardiovascular disease is increased in people with mental health disorders in
general and schizophrenia in particular. The causes are multifactorial, but it is known that …

There is great concern over cardiovascular disease in the schizophrenic population owing to
the high incidence of cardiovascular mortality. Increased cardiovascular mortality is related …

Cardiovascular aspects of antipsychotics : Current Opinion in Psychiatry Cardiovascular
aspects of antipsychotics : Current Opinion in Psychiatry Log in or Register Subscribe to …

The use of atypical antipsychotic agents has rapidly increased in the United States and
worldwide in the last decade. Nonetheless, many health care practitioners do not appreciate …

Patients with schizophrenia are at higher risk for medical illnesses than people in the
general population. Electrocardiographic and metabolic abnormalities that occur in patients …

The use of antipsychotic medications has now expanded to multiple mental health
conditions beyond schizophrenia. This has increased the overall population exposure to …

Schizophrenia is a psychotic disorder that exists at the more extreme end of a spectrum of
diseases, and significantly affects daily functioning. Cardiovascular adverse effects of …

The use of antipsychotics is hindered by the frequent occurrence of metabolic and
cardiovascular side effects, resulting in worsened quality of life and greater mortality as a …

Atypical antipsychotics are the treatment of choice for patients with schizophrenia. They are
generally better tolerated than conventional antipsychotics since most do not cause …

OBJECTIVE: The aim of the study is to review the absolute and relative impacts of the major
causes for premature mortality among patients with schizophrenia. DATA SOURCES: We …